Instrument Inactif

Communiqués VolitionRX Ltd OTC Bulletin Board

Actions

VNRX

US9286611077

Recherche biotechnologique et médicale

Communiqués

26/08	VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution Across $27+ Billion Total Addressable Markets	PR
26/08	Volition Announces Landmark Clinical Validation of Nu.Q® NETs Biomarker in Sepsis	PR
13/08	VolitionRX: Q2 Earnings Snapshot	AQ
13/08	VolitionRx : Announces Second Quarter 2026 Financial Results and Business Update	PU
12/08	Volition Demonstrates Utility of Rapid, Point-of-Care Finger-Prick Test in Sepsis Patients	PR
12/08	VolitionRx Limited Schedules Second Quarter 2026 Earnings Conference Call and Business Update	AQ
05/08	Volition Reports Publication of First Peer Reviewed Paper on New Capture-Seq™ Liquid Biopsy Technology	PR
30/07	Volition Advances Nu.Q® NETs Platform Towards Commercialization	PR
07/07	VolitionRx Announces Data Showing the Prognostic Value of its Nu.Q® Cancer Test	PR
17/06	VolitionRx Announces Collaboration with Sysmex	PR
08/06	VolitionRx Announces Pricing of $4.6 Million Public Offering	PR
03/06	VolitionRx Files New Patent Protecting its Nu.Q® NETs Test for Ebola Triage and Treatment Monitoring	PR
28/05	VolitionRx : Short Corporate Deck, May 2026	PU
28/05	VolitionRx : Corporate Presentation May 2026	PU
27/05	VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution Across $27+ Billion Total Addressable Markets	PR
15/05	VolitionRx : Short Corporate Deck, May 2026	PU
15/05	VolitionRx : Corporate Presentation May 2026	PU
15/05	VolitionRX: Q1 Earnings Snapshot	AQ
14/05	VolitionRx Limited Announces First Quarter 2026 Financial Results and Business Update	PR
11/05	VolitionRx Limited Schedules First Quarter 2026 Earnings Conference Call and Business Update	PR
06/05	VolitionRx Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats	PR
29/04	Volition Announces Breakthrough Finger-Prick Detection of Nucleosomes; Expanding Global Market Potential for Sepsis Testing	PR
23/04	VolitionRx Announces Acceptance of Compliance Plan by NYSE American	PR
20/04	Volition Launches rNuQ™ Webshop Broadening Product Range	PR
01/04	VolitionRx : Short Corporate Deck, Apr 2026	PU